Prété Géraldine, Couto-Silva Ana-Claudia, Trivin Christine, Brauner Raja
Université Paris Descartes and Assistance Publique Hôpitaux de Paris, Hôpital Bicêtre, Unité d'Endocrinologie Pédiatrique, 94270 Le Kremlin Bicêtre, France.
BMC Pediatr. 2008 Jul 4;8:27. doi: 10.1186/1471-2431-8-27.
It is sometimes difficult to distinguish between premature thelarche and precocious puberty in girls who develop breasts before the age of 8 years. We evaluated the frequencies of the signs associated with breast development and the factors influencing the presentation of girls with idiopathic central precocious puberty (CPP).
353 girls monitored 0.9 +/- 0.7 year after the onset of CPP.
The age at CPP was < 3 years in 2%, 3-7 years in 38% and 7-8 years in 60% of cases. Pubic hair was present in 67%, growth rate greater than 2 SDS in 46% and bone age advance greater than 2 years in 33% of cases. Breast development was clinically isolated in 70 (20%) cases. However, only 31 of these (8.8% of the population) had a prepubertal length uterus and gonadotropin responses to gonadotropin releasing hormone and plasma estradiol. The clinical picture of CPP became complete during the year following the initial evaluation.25% of cases were obese. The increase in weight during the previous year (3.7 +/- 1.4 kg) and body mass index were positively correlated with the statural growth and bone age advance (P < 0.0001). There was no relationship between the clinical-biological presentation and the age at puberty, the interval between the onset of puberty and evaluation, or the presence of familial CPP.
The variation in presentation of girls with CPP does not depend on their age, interval between the onset and evaluation, or familial factors. This suggests that there are degrees of hypothalamic-pituitary-ovarian activation that are not explained by these factors.
对于8岁前乳房发育的女孩,有时很难区分是性早熟还是单纯性乳房早发育。我们评估了与乳房发育相关体征的出现频率以及影响特发性中枢性性早熟(CPP)女孩临床表现的因素。
353名女孩在CPP发病后接受了0.9±0.7年的监测。
CPP发病年龄<3岁的占2%,3 - 7岁的占38%,7 - 8岁的占60%。67%的病例有阴毛,46%的病例生长速率大于2个标准差,33%的病例骨龄超前大于2岁。70例(20%)病例乳房发育在临床上是孤立的。然而,其中只有31例(占总人数的8.8%)子宫长度处于青春期前,且促性腺激素对促性腺激素释放激素及血浆雌二醇有反应。CPP的临床表现在初次评估后的一年内变得完全典型。25%的病例肥胖。前一年体重增加(3.7±1.4千克)和体重指数与身高增长及骨龄超前呈正相关(P<0.0001)。临床生物学表现与青春期年龄、青春期开始至评估的间隔时间或家族性CPP的存在无关。
CPP女孩临床表现的差异不取决于她们的年龄、发病与评估的间隔时间或家族因素。这表明存在一些下丘脑 - 垂体 - 卵巢激活程度无法用这些因素解释。